Objective: Nonalcoholic fatty liver disease (NAFLD) prevalence data in age- and BMI-matched reference groups are scarce. We aimed to investigate the prevalence, risk factors, and clinical characteristics of NAFLD in individuals with type 1 diabetes mellitus (T1DM).

Methods: A retrospective study was conducted on 1,132 people with T1DM who attended the Endocrinology Department from January 2014 to December 2022. After screening, a cohort of 832 T1DM patients was included for prevalence investigation. NAFLD diagnosis was based on ultrasound findings. A 1: 2 propensity score matching based on age, sex, and duration of diabetes was performed between the NAFLD and non-NAFLD groups. Additionally, 156 age-, sex-, and BMI-matched controls with normal glucose tolerance were enrolled, with laboratory measurements recorded. The t-test, χ2 test, and nonparametric test were used for comparison between the two groups when appropriate. Multivariate logistic regression models were used to assess risk factors for NAFLD.

Results: 61 individuals of NAFLD were identified among 832 individuals with T1DM, with a lower prevalence compared to the matched controls (7.3% vs 23%, P <0.05). The NAFLD group exhibited higher BMI, glucose, triglycerides (TG), ALT, GGT, and hsCRP levels but lower HDL-C compared to the non-NAFLD group (P < 0.05). Logistic regression analysis showed that BMI (OR= 1.27, 95% CI= 1.16 - 1.51), modified HOMA-IR (OR= 1.04 [1.01,1.08]), GGT (OR= 1.03 [1.01 - 1.05]), and TG (OR= 1.55 [1.19 - 2.13]) were associated with increased risk for NAFLD after adjusting for age, sex, metabolic syndrome, and its components (P<0.001). The predictive model combining BMI, modified HOMA-IR, GGT, and triglycerides demonstrated an area under the curve of 0.823 (95% CI= 0.76 - 0.89).

Conclusion: NAFLD is less prevalent in individuals with T1DM than in matched controls. A model integrating BMI, modified HOMA-IR, GGT, and triglycerides effectively predicts NAFLD risk in this population.

Disclosure

W. Jiang: None. Q. Huang: None. W. Xu: None. J. Yan: None. C. Wang: None. D. Yang: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.